919 Marketing Expands Life Science Client Roster

Holly Springs, North Carolina – 919 Marketing Company, a top ten Triangle area marketing consulting and public relations firm, announced today that it has further expanded its life science division with the addition of Gentris Corporation and Glenveigh Pharmaceuticals.

Headquartered in Research Triangle Park, Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions. 919 Marketing will devise and implement strategic public relations programs aimed at increasing Gentris’ mindshare within relevant sales channels. “919 Marketing’s proven track record of accelerating market awareness for biotechnology companies was the key factor in our decision to sign them as our strategic public relations firm,” said Michael Murphy, president and CEO of Gentris.

Glenveigh Pharmaceuticals specializes in pregnancy health to improve outcomes for mothers and their babies. 919 Marketing will provide strategic planning, brand development, print and digital sales materials, as well as public relations services to Glenveigh. “We chose 919 Marketing because they displayed a deep understanding of an emerging company’s needs. Their high expertise in devising marketing programs that successfully showcase brands to key players in the pharmaceutical industry is very impressive. There was no better choice for us,” said Rick Proctor, president of Glenveigh.

Over the past 10 years, 919 Marketing has provided strategic marketing and public relations services to dozens of companies across the country, from large global players to start-up companies eager to make a difference in their industry. “We are excited to be working with Gentris and Glenveigh as they strive to introduce new and improved solutions in personalized medicine and maternal-fetal care,” said David Chapman, president of 919 Marketing.

# # #

About 919 Marketing

Celebrating their 10th Anniversary, 919 Marketing is a hybrid business consulting/marketing communications firm, located just minutes from North Carolina’s Research Triangle Park. The 919 team of seasoned, senior-level consultants develops winning business strategies and provides the marketing horsepower required to produce clear, measurable and recognizable results for a roster of life sciences companies. For more information on 919 Marketing, please call 919.557.7890 or visit www.919marketing.com.

About Gentris Corporation

Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions. As pioneers in the field of pharmacogenomics, Gentris helps pharmaceutical companies and clinical research organizations effectively integrate pharmacogenomics into their drug development programs to deliver safer, more effective compounds to the market sooner. Gentris is developing diagnostic test kits and validated reference controls that will bring the promise of personalized medicine to physicians and patients, which will enhance patient management, improve patients' response to therapy and revolutionize medicine through pharmacogenomics. For additional information, please visit www.gentris.com.

About Glenveigh Pharmaceuticals

Headquartered in North Carolina’s Research Triangle Park, Glenveigh Pharmaceuticals is building a world-class company specializing in pregnancy health to improve outcomes for mothers and their babies. Glenveigh was founded in 2004 to fill the significant unmet medical needs in obstetrics and maternal-fetal medicine. The company has an existing drug in a Phase II study for preeclampsia, and is developing diagnostic tests that will enable more rapid diagnosis and treatment by physicians. Glenveigh is uniquely positioned to meet these challenges with its team of prominent physicians, scientists, and executives. To learn more about Glenveigh, please visit www.glenveigh.com.